Tech Company Financing Transactions
InterVene Funding Round
On 3/25/2015, InterVene landed $5.9 million in Series A funding from Boston Scientific Corporation, Green Park & Golf Ventures and LaunchCapital.
Transaction Overview
Company Name
Announced On
3/25/2015
Transaction Type
Venture Equity
Amount
$5,900,000
Round
Series A
Investors
Proceeds Purpose
The Series A funding will support a two-stage clinical trial.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
415 Grand Ave. 302
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
InterVene is an up and coming medical device start-up company.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Fletcher Wilson
Chief Operating Officer
Jeffrey Elkins
VP - R & D
Michi Garrison
VP - Regulatory Affairs
Tracy Roberts
Browse more venture capital transactions:
Prev: 3/25/2015: Kindara venture capital transaction
Next: 3/25/2015: Keywee venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document tech company VC transactions. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs